Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Cambridge Healthtech Institute to Hold Inaugurual Next-Generation Pathology SymposiaCambridge Healthtech Institute to Hold Inaugurual Next-Generation Pathology Symposia at 19th International Molecular Med Tri-CON 2012.
February 19-20, 2012 | San Francisco, CA | Part of the Molecular Med Tri-Con Next-generation sequencing, digital pathology and other innovative technologies are rapidly transforming the field of pathology and tissue analysis. Along with these technological advances, we are also witnessing an expansion in pathology applications, both in the pharmaceutical industry and research, and in the clinic. This symposium is designed to bring together pathologists and tissue analysis specialists working in the industry as well as in academic settings. The program will present solutions and case studies for various tissue analysis applications and will feature an array of novel technologies. Keynote Presentation: Carlos Cordon-Cardo, M.D., Ph.D., Irene Heinz Given and John LaPorte Given Professor and Chairman, Department of Pathology, Professor, Department of Genetics and Genomic Sciences, The Mount Sinai School of Medicine; Professor and Director, Department of Pathology, The Mount Sinai Hospital Presentations Include: Development of Next-Generation Sequencing as a Clinical Test and Requirements for Laboratory Standards Aziz, Ph.D., Director, Molecular Medicine, Transformation Program Office, College of American Pathologists Clinical Interpretation of Next-Generation Sequencing Tests: A Whole New World Wayne W. Grody, M.D., Ph.D., Professor, Divisions of Medical Genetics and Molecular Pathology, Departments of Pathology & Lab. Medicine, Pediatrics, and Human Genetics, Director, Diagnostic Molecular Pathology Laboratory, University of California, Los Angelas School of Medicine Molecular is Nifty...Experiences Trying to Keep it Thrifty? Jeffrey A. Kant, M.D., Ph.D., Director, Division of Molecular Diagnostics, University of Pittsburgh Medical Center Health System Opportunities and Challenges of Molecular Diagnostics and Personalized Cancer Therapy Dongfeng (Dan) Tan, M.D., Full Professor, Pathology and Laboratory Medicine, MD Anderson Cancer Center Transformative Systems Pathology: Moving Omics to Clinics Michael Roehrl, M.D., Assistant Professor, Pathology and Laboratory Medicine, Boston Medical Center Bringing Biobanks to Life: Rapid and Highly Efficient Generation of Cell Lines from Pathology Specimens Richard Schlegel, M.D., Ph.D., Professor and Chair, Pathology, Georgetown University Medical School Next-Generation Pre-Clinical Xenograft Models Yuzhuo Wang, Ph.D., Associate Professor, Urologic Science, University of British Columbia Translational Pathology Research: The Quest for Predictive BioMarkers Suzanne K. Coberly, M.D., FCAP, Pathologist Director, Amgen Quantification and Standardization of in situ Measurement of Biomolecules in Formalin Fixed Paraffin Embedded Tissue David L. Rimm, M.D., Ph.D., Professor of Pathology; Director, Medical Studies; Director, Pathology Tissue Services, Yale School of Medicine Power of the Taqman Protein Assay (TPA) for Quantitative Protein Determination in Pathological Samples Leendert Looijenga, Professor & Head, Laboratory Experimental Patho-Oncology, Pathology, Erasmus Medical Center PANEL DISCUSSION: Molecular Pathology as the Driving Force for Precision Medicine Moderator: Richard Levenson, M.D., Brighton Consulting Group Multiplexing in Pathology: How Far Can We Go? Richard Levenson, M.D., Brighton Consulting Group Exome Sequencing for Candidate Gene Discovery in Inherited Disorders Karl V. Voelkerding, M.D., Professor of Pathology, University of Utah; Medical Director, Genomics and Bioinformatics, ARUP Laboratories Biomarker Discovery by NexGen Sequencing of Immune Repertoire Jian Han, M.D., Ph.D., Faculty Investigator, R10K, HudsonAlpha Institute for Biotechnology Leveraging the Power of Digital Pathology in Translational Research Mark Lloyd, M.S., Staff Scientist, Analytic Microscopy, H. Lee Moffitt Cancer Center Marilyn Bui, M.D., Ph.D., Associate Professor and Director, Anatomic Pathology and Analytic Microscopy, H. Lee Moffitt Cancer Center Automated Feature Classification and Image-Based Feature Search in Whole Slide Image Data Sets Ulysses G.J. Balis, M.D., Associate Professor and Director, Division of Pathology Informatics, University of Michigan High Resolution Pathology for Personalized Medicine Using Automated Image Analysis Algorithms Raj Bandaru, Associate Director, Informatics and Statistics Operations, Oncology Translational Laboratories, Novartis Pharmaceuticals For more information visit triconference.com/ # # # Since 1992, Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|